IBDEI1R5 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,27994,2)
 ;;=^5003400
 ;;^UTILITY(U,$J,358.3,27995,0)
 ;;=F18.959^^113^1367^15
 ;;^UTILITY(U,$J,358.3,27995,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27995,1,3,0)
 ;;=3^Inhalant Induced Psychotic D/O w/o Use D/O
 ;;^UTILITY(U,$J,358.3,27995,1,4,0)
 ;;=4^F18.959
 ;;^UTILITY(U,$J,358.3,27995,2)
 ;;=^5003412
 ;;^UTILITY(U,$J,358.3,27996,0)
 ;;=F18.99^^113^1367^22
 ;;^UTILITY(U,$J,358.3,27996,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27996,1,3,0)
 ;;=3^Inhalant Related D/O,Unspec
 ;;^UTILITY(U,$J,358.3,27996,1,4,0)
 ;;=4^F18.99
 ;;^UTILITY(U,$J,358.3,27996,2)
 ;;=^5133360
 ;;^UTILITY(U,$J,358.3,27997,0)
 ;;=F18.21^^113^1367^25
 ;;^UTILITY(U,$J,358.3,27997,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27997,1,3,0)
 ;;=3^Inhalant Use D/O,Mod/Sev,In Remission
 ;;^UTILITY(U,$J,358.3,27997,1,4,0)
 ;;=4^F18.21
 ;;^UTILITY(U,$J,358.3,27997,2)
 ;;=^5003393
 ;;^UTILITY(U,$J,358.3,27998,0)
 ;;=F18.11^^113^1367^24
 ;;^UTILITY(U,$J,358.3,27998,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27998,1,3,0)
 ;;=3^Inhalant Use D/O,Mild,In Remission
 ;;^UTILITY(U,$J,358.3,27998,1,4,0)
 ;;=4^F18.11
 ;;^UTILITY(U,$J,358.3,27998,2)
 ;;=^5151305
 ;;^UTILITY(U,$J,358.3,27999,0)
 ;;=Z00.6^^113^1368^1
 ;;^UTILITY(U,$J,358.3,27999,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27999,1,3,0)
 ;;=3^Exam Control in Clinical Research
 ;;^UTILITY(U,$J,358.3,27999,1,4,0)
 ;;=4^Z00.6
 ;;^UTILITY(U,$J,358.3,27999,2)
 ;;=^5062608
 ;;^UTILITY(U,$J,358.3,28000,0)
 ;;=F45.8^^113^1369^13
 ;;^UTILITY(U,$J,358.3,28000,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28000,1,3,0)
 ;;=3^Somatoform Symp & Rel D/O,Oth Spec
 ;;^UTILITY(U,$J,358.3,28000,1,4,0)
 ;;=4^F45.8
 ;;^UTILITY(U,$J,358.3,28000,2)
 ;;=^331915
 ;;^UTILITY(U,$J,358.3,28001,0)
 ;;=F45.0^^113^1369^12
 ;;^UTILITY(U,$J,358.3,28001,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28001,1,3,0)
 ;;=3^Somatization D/O
 ;;^UTILITY(U,$J,358.3,28001,1,4,0)
 ;;=4^F45.0
 ;;^UTILITY(U,$J,358.3,28001,2)
 ;;=^112280
 ;;^UTILITY(U,$J,358.3,28002,0)
 ;;=F45.9^^113^1369^14
 ;;^UTILITY(U,$J,358.3,28002,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28002,1,3,0)
 ;;=3^Somatoform Symp & Rel D/O,Unspec
 ;;^UTILITY(U,$J,358.3,28002,1,4,0)
 ;;=4^F45.9
 ;;^UTILITY(U,$J,358.3,28002,2)
 ;;=^5003592
 ;;^UTILITY(U,$J,358.3,28003,0)
 ;;=F45.1^^113^1369^11
 ;;^UTILITY(U,$J,358.3,28003,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28003,1,3,0)
 ;;=3^Somatic Symptom D/O
 ;;^UTILITY(U,$J,358.3,28003,1,4,0)
 ;;=4^F45.1
 ;;^UTILITY(U,$J,358.3,28003,2)
 ;;=^5003585
 ;;^UTILITY(U,$J,358.3,28004,0)
 ;;=F44.4^^113^1369^4
 ;;^UTILITY(U,$J,358.3,28004,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28004,1,3,0)
 ;;=3^Conversion D/O w/ Motor Symp or Deficit
 ;;^UTILITY(U,$J,358.3,28004,1,4,0)
 ;;=4^F44.4
 ;;^UTILITY(U,$J,358.3,28004,2)
 ;;=^5003579
 ;;^UTILITY(U,$J,358.3,28005,0)
 ;;=F44.6^^113^1369^1
 ;;^UTILITY(U,$J,358.3,28005,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28005,1,3,0)
 ;;=3^Conversion D/O w/ Anesthesia or Sensory Loss
 ;;^UTILITY(U,$J,358.3,28005,1,4,0)
 ;;=4^F44.6
 ;;^UTILITY(U,$J,358.3,28005,2)
 ;;=^5003581
 ;;^UTILITY(U,$J,358.3,28006,0)
 ;;=F44.5^^113^1369^2
 ;;^UTILITY(U,$J,358.3,28006,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28006,1,3,0)
 ;;=3^Conversion D/O w/ Attacks or Seizures
 ;;^UTILITY(U,$J,358.3,28006,1,4,0)
 ;;=4^F44.5
 ;;^UTILITY(U,$J,358.3,28006,2)
 ;;=^5003580
 ;;^UTILITY(U,$J,358.3,28007,0)
 ;;=F44.7^^113^1369^3
